Vaccino, Locatelli: “Definitive yes to Pfizer convince undecided”

The definitive go-ahead for Pfizer / BioNTech’s anti-Covid vaccine by the American agency Fda? “This decision testifies that the vaccine in question, as well as the other vaccines authorized for clinical use in emergency use or according to the conditional approval criterion in Europe, meet the most stringent scientific criteria relating to the production process, safety profile and immunizing efficacy “. Thus Franco Locatelli, coordinator of the Technical Scientific Committee and Hematologist of the Bambino Gesù comments in an interview with the ‘Corriere della Sera’. “The objection that the vaccines have been approved too quickly loses any consistency – he underlines -. None of the more rigorous evaluation steps regarding safety have been skipped. The hope and hope is that this could represent a new incentive to adhere to the vaccination campaign, especially in those populations of subjects where the lethality rate of the infection is particularly high. I am referring in particular to Italians over the age of 50. But let’s not forget the importance of protecting even the youngest, adolescents from 12 years of age inclusive “. For Locatelli, “the hypothesis of extending the green pass to 12 months is more than reasonable also in light of the progressive acquisition of information on the duration of the vaccination response. The expiry date was initially set at 6 months, and then moved to 9, precisely because we are progressively learning how long the protective effect conferred by the vaccine lasts. The first vaccinations in the world began about 10 months ago. As of today there is no evidence that there is a substantial loss of the protective effect offered by immunization in first vaccinated, the decision to extend the deadline to 12 months has a solid basis “he concludes.